Gabon vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Gabon
3.2%
in 2024
Timor-Leste
1.0%
in 2024
Gabon rank
3rd
Timor-Leste rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Gabon
- Timor-Leste
How they compare
Gabon currently reports 3.2% against 1.0% in Timor-Leste, a difference of 2.2%.
That makes Gabon's figure about 3.2 times Timor-Leste's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Timor-Leste ahead.
Gabon ranks 3rd and Timor-Leste ranks 3rd of 215 countries.
Gabon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.9% | 2.5% | 0.5% | Gabon |
| 2020s | 3.1% | 1.3% | 1.8% | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Gabon or Timor-Leste?
- Gabon, at 3.2% against 1.0% in Timor-Leste as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Gabon and Timor-Leste?
- 2.2%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Timor-Leste?
- 10 years are reported by both, from 2015 to 2024.
- How do Gabon and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Gabon ranks 3rd and Timor-Leste ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.